HALO logo

Halozyme Therapeutics (HALO) Long term debt

Annual long term debt:

$1.51B+$6.55M(+0.44%)
December 31, 2024

Summary

  • As of today (June 22, 2025), HALO annual long term debt is $1.51 billion, with the most recent change of +$6.55 million (+0.44%) on December 31, 2024.
  • During the last 3 years, HALO annual long term debt has risen by +$718.54 million (+91.27%).
  • HALO annual long term debt is now at all-time high.

Performance

HALO Long term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHALObalance sheet metrics

Quarterly long term debt:

$1.51B+$1.65M(+0.11%)
March 31, 2025

Summary

  • As of today (June 22, 2025), HALO quarterly long term debt is $1.51 billion, with the most recent change of +$1.65 million (+0.11%) on March 31, 2025.
  • Over the past year, HALO quarterly long term debt has increased by +$6.57 million (+0.44%).
  • HALO quarterly long term debt is now at all-time high.

Performance

HALO Quarterly long term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHALObalance sheet metrics

Long term debt Formula

Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt

HALO Long term debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+0.4%+0.4%
3 y3 years+91.3%+91.3%
5 y5 years+293.1%+289.9%

HALO Long term debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+91.3%at high+91.3%
5 y5-yearat high+293.1%at high+289.9%
alltimeall timeat high>+9999.0%at high>+9999.0%

HALO Long term debt History

DateAnnualQuarterly
Mar 2025
-
$1.51B(+0.1%)
Dec 2024
$1.51B(+0.4%)
$1.51B(+0.1%)
Sep 2024
-
$1.50B(+0.1%)
Jun 2024
-
$1.50B(+0.1%)
Mar 2024
-
$1.50B(+0.1%)
Dec 2023
$1.50B(+0.4%)
$1.50B(+0.1%)
Sep 2023
-
$1.50B(+0.1%)
Jun 2023
-
$1.50B(+0.1%)
Mar 2023
-
$1.49B(+0.1%)
Dec 2022
$1.49B(+89.6%)
$1.49B(+0.1%)
Sep 2022
-
$1.49B(+30.0%)
Jun 2022
-
$1.15B(+45.6%)
Mar 2022
-
$788.10M(+0.1%)
Dec 2021
$787.25M(+105.5%)
$787.25M(+0.1%)
Sep 2021
-
$786.45M(+0.1%)
Jun 2021
-
$785.57M(+0.1%)
Mar 2021
-
$784.73M(+99.4%)
Sep 2020
-
$393.63M(+0.9%)
Jun 2020
-
$390.08M(+0.9%)
Mar 2020
-
$386.57M(+0.9%)
Dec 2019
$383.05M(+998.4%)
$383.05M(+4015.2%)
Sep 2019
-
$9.31M(-33.9%)
Jun 2019
-
$14.08M(-24.9%)
Mar 2019
-
$18.74M(-46.3%)
Dec 2018
$34.87M
$34.87M(-39.8%)
DateAnnualQuarterly
Sep 2018
-
$57.94M(-26.7%)
Jun 2018
-
$79.08M(-23.0%)
Mar 2018
-
$102.70M(-17.9%)
Dec 2017
$125.14M(-37.2%)
$125.14M(-13.9%)
Sep 2017
-
$145.42M(-12.1%)
Jun 2017
-
$165.52M(-10.3%)
Mar 2017
-
$184.43M(-7.4%)
Dec 2016
$199.23M(+612.3%)
$199.23M(-0.3%)
Sep 2016
-
$199.80M(-2.5%)
Jun 2016
-
$204.85M(+21.5%)
Mar 2016
-
$168.60M(+502.8%)
Dec 2015
$27.97M(-43.9%)
$27.97M(-18.0%)
Sep 2015
-
$34.09M(-15.0%)
Jun 2015
-
$40.10M(-12.8%)
Mar 2015
-
$45.98M(-7.8%)
Dec 2014
$49.86M(+0.2%)
$49.86M(+25.4%)
Sep 2014
-
$39.76M(-8.8%)
Jun 2014
-
$43.61M(-8.0%)
Mar 2014
-
$47.39M(-4.8%)
Dec 2013
$49.77M(+60.0%)
$49.77M(+89.0%)
Sep 2013
-
$26.33M(-6.5%)
Jun 2013
-
$28.18M(-5.4%)
Mar 2013
-
$29.77M(-4.3%)
Dec 2012
$31.11M(>+9900.0%)
$31.11M(>+9900.0%)
Dec 2011
$0.00
$0.00

FAQ

  • What is Halozyme Therapeutics annual long term debt?
  • What is the all time high annual long term debt for Halozyme Therapeutics?
  • What is Halozyme Therapeutics annual long term debt year-on-year change?
  • What is Halozyme Therapeutics quarterly long term debt?
  • What is the all time high quarterly long term debt for Halozyme Therapeutics?
  • What is Halozyme Therapeutics quarterly long term debt year-on-year change?

What is Halozyme Therapeutics annual long term debt?

The current annual long term debt of HALO is $1.51B

What is the all time high annual long term debt for Halozyme Therapeutics?

Halozyme Therapeutics all-time high annual long term debt is $1.51B

What is Halozyme Therapeutics annual long term debt year-on-year change?

Over the past year, HALO annual long term debt has changed by +$6.55M (+0.44%)

What is Halozyme Therapeutics quarterly long term debt?

The current quarterly long term debt of HALO is $1.51B

What is the all time high quarterly long term debt for Halozyme Therapeutics?

Halozyme Therapeutics all-time high quarterly long term debt is $1.51B

What is Halozyme Therapeutics quarterly long term debt year-on-year change?

Over the past year, HALO quarterly long term debt has changed by +$6.57M (+0.44%)
On this page